7 Multiple Sclerosis Headlines

admin avatar

by admin |

Share this article:

Share article via email

1 – 10 Tips for Self-Managing Your Multiple Sclerosis

10 tips managing multipleSclerosis

Read more about how to self-manage your multiple sclerosis.

Read full article: http://bit.ly/1o6tYly

 

2 – The Bitter(sweet) Truth About Multiple Sclerosis

news_11_Artboard 343 copy 65

“Oh sugar, sugar…

Diet Coke is my “thing.” I have a love/hate relationship with it – I hate being without it but I know I need to end our affair. I like to think that it helps me stay awake, but in reality, it gives me headaches and an upset stomach. I don’t even love the taste, but I’m still drawn to it. Why?”

Read full article here: http://bit.ly/1RyyHoA

3 – What Having Multiple Sclerosis Feels Like

news_11_Artboard 343 copy 38

Since the central nervous system (CNS) is affected in MS, all of the organs which are controlled by the CNS are affected by the disease at different points of time within its progression.

Learn more about the most common multiple sclerosis symptoms.

Read full article here: http://bit.ly/1VRIJGR

4 – MS Lesions in Cerebellum Ably Predict Disability Levels and Disease Progression, Study Suggests

news_11_Artboard 343 copy 66

Damage to the cerebellum in people with multiple sclerosis (MS) is due more to the death of actual nerve cells than the destruction of white matter connections, a new study out of Italy suggests. The article, which challenges previous ideas about how brain damage in MS occurs, is titled “MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis“ and appeared in Multiple Sclerosis Journal.

Read full article here: http://bit.ly/1UWN0Ib

5 – MS Relapses During Natalizumab Therapy Traced to Drug’s Greater Impact on Regulatory T-cells

news_11_Artboard 343 copy 67

Natalizumab (Tysabri) harnesses multiple sclerosis (MS) activity by targeting CD49, a molecule on the surface of immune cells. Now, researchers found that the drug reduces the factor on regulatory T-cells to a greater extent than on inflammatory T-cells — a mechanism that might explain disease exacerbation during treatment.

Read full article here: http://bit.ly/1VRIhbE

6 – Oral MS Drug Derived from Plant Peptide Seen to Stop Disease Progression in Mice

news_11_Artboard 343 copy 68

Researchers, working with an animal model of multiple sclerosis (MS) discovered that oral treatment with a synthesized plant peptide, known as cyclotide, halted the progression of clinical symptoms without side effects. The finding offers new hope for the development of an easily available and orally deliverable treatment that might slow or even prevent the onset of MS.

Read full article here: http://bit.ly/1RynWmp

7 – Rosacea Appears to Be Linked to Multiple Sclerosis in Women, Study Reports

news_11_Artboard 343 copy 64

Rosacea is an inflammatory skin condition affecting mostly fair-skinned individuals. A study from the University of Copenhagen, Denmark, recently showed that the condition in women is also associated with multiple sclerosis (MS).

Read full article here: http://bit.ly/1RnBd38

The Multiple Sclerosis Podcast


Survey Icon

Video